[ET Net News Agency, 22 October 2025]  SINOPHARM (01099) rose 3% to HK$19.28. 
  It hits an intra-day high of HK$19.3, hitting an 1-month high, breaking above the 250-D 
SMA of HK$18.872, and an intra-day low of HK$18.69. The total shares traded was 1.75  
million, with a value of HK$33.39m. The active buy/sell ratio is 72:28, with net buying 
turnover of HK$13.43m. MERRILL LYNCH FE accounts for greatest net responsive buying 
turnover of HK$1.66m, with volume weighted average price of HK$19.128. CHINA INV INFO 
accounts for greatest net responsive selling turnover of HK$2.55m, with volume weighted 
average price of HK$19.18. The stock has risen a combined 4.7% over the past 3 consecutive
trading days. 
  The Hang Seng Index now fell 238 points, or 0.9% to 25,789. 
  
          Basic Information 
          ================= 
  
  --------------------------------- 
  Nominal   19.280 % Chg    +2.99%
  High      19.300 Low      18.690
  Shares Tr  1.75m Turnover 33.39m
  10-D SMA  18.673 %H.V     16.585
  20-D SMA  18.554 VWAP     19.089
  50-D SMA  18.813 RSI14    62.249
  --------------------------------- 
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is 
72:28, with net buying turnover of HK$13.43m, rising a combined 4.7% over the past 3  
consecutive trading days
  
Performance of stocks in the same sector or of relevance
========================================================
  
  Stock (Code)           Price (HK$) Change (%) 
  ----------------------------------------------
  SINOPHARM (01099)            19.28      +2.99 
  JIANGXI COPPER (00358)       30.68      -4.84 
  CCB (00939)                   7.79      -0.38 
  CHINA MOBILE (00941)         85.10      -0.12 
  CHINA SHENHUA (01088)        40.46      -1.60 
  HUA HONG SEMI (01347)        73.45      -5.47 
  SD GOLD (01787)              33.24      -6.21 
  ZHAOJIN MINING (01818)       28.34      -7.20 
  CHINA LIFE (02628)           24.44      -2.00 
  ZIJIN MINING (02899)         30.52      -5.63 
  ----------------------------------------------
  (ed)